Clinical Trials Browser

Phase 2 × INDUSTRY × danusertib × Clear all

NCT00766324 2014-05-28

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Phase 2 Completed

Metastatic Hormone Refractory Prostate Cancer

NCT00872300 2014-05-28

PHA-739358 for the Treatment of Multiple Myeloma

Phase 2 Terminated

Multiple Myeloma